Renaissance Technologies
BOLD

Renaissance Technologies’s Audentes Therapeutics, Inc BOLD Stock Holding History

Renaissance Technologies’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-228,100
Closed -$13.7M – 4016
2019
Q4 		$13.7M Buy
228,100
+149,400
+190% +$5.61M 0.01% 1238
2019
Q3 		$2.21M Buy
+78,700
New +$2.69M ﹤0.01% 2230
2018
Q2 		– Sell
-74,600
Closed -$2.24M – 3657
2018
Q1 		$2.24M Buy
74,600
+21,100
+39% +$714K ﹤0.01% 2268
2017
Q4 		$1.67M Buy
+53,500
New +$1.47M ﹤0.01% 2444

Renaissance Technologies's BOLD Position: Q1 2020 in Review

Renaissance Technologies sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 228,100 shares — an estimated $13.7M sold.

Renaissance Technologies first reported a position in BOLD in Q4 2017 and held it in 4 quarters. The position peaked at $13.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Renaissance Technologies reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Renaissance Technologies sold 228,100 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $13.7M.
  • Renaissance Technologies first reported a position in Audentes Therapeutics, Inc in Q4 2017 and held it in 4 quarters.
  • Renaissance Technologies's Audentes Therapeutics, Inc position peaked at $13.7M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.